N.D. Admin. Code § 33-44-01-48
1. Usable marijuana required to be tested for microbiological contaminants under sections 33-44-01-42, 33-44-01-43, and 33-44-01-44 must be sampled using appropriate aseptic techniques.
2. For purposes of the microbiological test, a usable marijuana sample is deemed to have passed if it meets the following standards for microbial and fungal limits in colony forming units per gram (CFU/g):
| Concentrates | Dried Leaves or Flowers and Medical Cannabinoid Products | |
|---|---|---|
| Total viable aerobic bacteria | 104 CFU/g | 105 CFU/g |
| Total yeast and mold | 103 CFU/g | 104 CFU/g |
| Total coliforms | 102 CFU/g | 103 CFU/g |
| Bile-tolerant gram-negative bacteria | 102 CFU/g | 103 CFU/g |
| Escherichia coli (pathogenic strains) and salmonella species | Not detected in one gram | Not detected in one gram |
3. For purposes of the mycotoxin test, a usable marijuana sample is deemed to have passed if it meets the following standards:
a. The total of aflatoxin B1, B2, G1, and G2 is less than 20 µg/kg of substance; and b. Ochratoxin A is less than 20 µg/kg of substance.
4. If the samples do not pass testing standards for microbiological contaminants or mycotoxins, the manufacturing facility shall comply with section 33-44-01-52.
History: Effective April 1, 2018.